Artal Group S.A. Bristol Myers Squibb CO Call Options Transaction History

Artal Group S.A.

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $61.5 Million - $73.7 Million	-1,000,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $57.7 Million - $65.4 Million	1,000,000 New	1,000,000 $62 Million
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $172 Million - $225 Million	-3,500,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $53.5 Million - $63.4 Million	1,250,000 Added 55.56%	3,500,000 $177 Million
Q2 2019 Aug 09, 2019	BUY	$44.62 - $49.34 $71.4 Million - $78.9 Million	1,600,000 Added 246.15%	2,250,000 $102 Million
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $4.51 Million - $5.38 Million	100,000 Added 18.18%	650,000 $31 Million
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $9.75 Million - $12.6 Million	-200,000 Reduced 26.67%	550,000 $28.6 Million
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $27.6 Million - $31.1 Million	-500,000 Reduced 40.0%	750,000 $46.6 Million
Q2 2018 Aug 10, 2018	BUY	$50.53 - $62.98 $17.7 Million - $22 Million	350,000 Added 38.89%	1,250,000 $69.2 Million
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $15 Million - $16.3 Million	250,000 Added 38.46%	900,000 $55.2 Million
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $35.9 Million - $41.4 Million	650,000	650,000 $41.4 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.